38 participants
A Multicenter, 4-week Crossover (Total Duration 12 Weeks) to Determine the Impact of QVA149 on Nocturnal Oxygen Levels in Chronic Obstructive Pulmonary Disease (COPD)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2018-08-06
- Start Date:
- 2014-11-30
- Completion:
- 2016-06-26
Conditions
- Chronic Obstructive Pulmonary Disease
Interventions
- DRUG